Drug Delivery System
Online ISSN : 1881-2732
Print ISSN : 0913-5006
ISSN-L : 0913-5006
Feature articles “DDS formulation in clinical development” Editor : Yasuhiro Matsumura
Clinical trials of NK105, a paclitaxel incorporating micellar nanoparticle formation
Ken Kato
Author information
Keywords: drug delivery system, polymeric micelle, paclitaxel, phase I study, phase II study
JOURNAL FREE ACCESS

2009 Volume 24 Issue 1 Pages 28-34

Details
Download PDF (576K)
Download citation RIS

(compatible with EndNote, Reference Manager, ProCite, RefWorks)

BIB TEX

(compatible with BibDesk, LaTeX)

Text
How to download citation
Contact us
Abstract
NK105 is a polymer micelle that involves the paclitaxel. According to the results of the phase I study, recommended dosage is 150 mg/m2, and the dose limiting toxicity is neutropenia. Phase II study against gastric cancer was started.
Content from these authors
© 2009 Japan Society of Drug Delivery System
Next article
Favorites & Alerts

Recently viewed articles
Share this page
feedback
 Top